Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublinesin vitro Bridget T. HillRichard D. H. WhelanLouise K. Hosking Preclinical Studies Pages: 169 - 182
In vitro comparison of cytotoxic effects of crotoxin against three human tumors and a normal human epidermal keratinocyte cell line Colette J. RuddLuis J. ViskatisMartin A. Etcheverry Brief Report Pages: 183 - 184
Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol Dominic FanGeorge PosteIsaiah J. Fidler Preclinical Studies Pages: 185 - 195
Intraperitoneal 5-fluoro-2′-deoxyuridine with escalating doses of leucovorin: Pharmacology and clinical tolerance Franco M. MuggiaAnil TulpuleKenneth K. Chan Phase I Studies Pages: 197 - 206
Pyrazine diazohydroxide (NSC-361456) Madhav V. DhodapkarRonald L. RichardsonMatthew M. Ames Phase I Studies Pages: 207 - 216
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas Jorge E. RomagueraM. Alma RodriguezFernando Cabanillas Phase II Studies Pages: 217 - 222
Phase I/II study of cisplatin, 5-fluorouracil and α-interferon for recurrent carcinoma of the head and neck Martin H. HuberMihran ShirinianWaun Ki Hong Phase II Studies Pages: 223 - 229
Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma Alessandro TestolinGianfranco RecherGiampietro Gasparini Brief Report Pages: 231 - 234
Phase II study of deoxyspergualin in metastatic breast cancer Kapil DhingraVicente ValeroGabriel Hortobagyi Phase II Studies Pages: 235 - 241
Phase II clinical trial of didemnin B in previously treated small cell lung cancer Dong M. ShinPaul Y. HoloyeWaun Ki Hong Phase II Studies Pages: 243 - 249
Phase II trial of fotemustine in patients with metastatic malignant melanoma Carla I. FalksonGeoffrey FalksonHendré C. Falkson Phase II Studies Pages: 251 - 254
Trimetrexate in advanced hormone-refractory prostate cancer Robert S. WitteBeow Yong YeapDonald L. Trump Phase II Studies Pages: 255 - 258
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma Micheal R. GreverJacqueline BenedettiShaker R. Dakhil Brief Report Pages: 259 - 261
Phase II trial of piroxantrone in metastatic gastric adenocarcinoma Richard PazdurBeth BreadyRodger J. Winn Brief Report Pages: 263 - 265
Phase II study of amonafide in gastric adenocarcinoma Michael R. MullaneRichard L. SchilskyAl. B. Benson III Phase II Studies Pages: 267 - 270